Last updated: March 9, 2026
As the understanding of dementia continues to evolve, so does the recognition that cognitive health depends on more than genetics or aging alone. Research now points to a wide range of modifiable lifestyle factors that can meaningfully reduce dementia risk. This guide from the Arizona Homeopathic and Integrative Medical Association explores evidence-based integrative approaches to supporting brain health alongside conventional care.
Cognitive decline and dementia represent one of the fastest-growing health crises in the United States, affecting millions of individuals and placing extraordinary strain on families, caregivers, and the healthcare system. An estimated 7.2 million Americans aged 65 and older are living with Alzheimer’s dementia in 2025, a number projected to nearly double by 2060, according to the Alzheimer’s Association.
The scale of this crisis extends well beyond the individuals diagnosed. Nearly 12 million Americans provide unpaid caregiving for people with Alzheimer’s or other dementias, contributing over 19 billion hours of care valued at more than $413 billion in 2024. The total cost of dementia care in the United States is projected to reach $384 billion in 2025 and approach nearly $1 trillion by 2050.
Yet as Dale Bredesen, MD – neurologist and Senior Director of Precision Brain Health at Pacific Neuroscience Institute – has stated: “Cognitive decline, though increasingly common, is not a natural or inevitable part of aging. Instead, it is often the result of a confluence of factors – including poor diet, chronic inflammation, lack of exercise, toxin exposure, stress, and inadequate sleep – that, over time, chip away at mental acuity.” This perspective underscores why integrative, preventive approaches are receiving serious scientific attention.
An estimated 7.2 million Americans aged 65 and older are living with Alzheimer’s dementia in 2025, representing approximately 1 in 9 people (11%) in that age group. This figure is projected to reach 13.8 million by 2060 as the population ages, according to the Alzheimer’s Association 2025 Facts and Figures report.
The following table summarizes the scope of the dementia caregiving crisis in the United States based on 2025 Alzheimer’s Association data:
| Measure | Figure | Year |
|---|---|---|
| Unpaid caregivers in the U.S. | Nearly 12 million | 2024 |
| Hours of unpaid care provided | Over 19 billion hours | 2024 |
| Economic value of unpaid care | More than $413 billion | 2024 |
| Total U.S. dementia care costs | $384 billion | 2025 |
| Projected U.S. dementia care costs | Nearly $1 trillion | 2050 |
Beyond the financial numbers, a 2025 qualitative study published in JAMA Network Open found that patients and care partners weigh complex factors when evaluating treatment decisions – including quality of life, treatment burden, and the desire for options that go beyond pharmaceutical management alone. This emotional and practical complexity is a key reason many families explore integrative approaches.
The conventional treatment landscape for Alzheimer’s disease in 2026 includes newly approved disease-modifying therapies and more than 230 active NIH-funded clinical trials, representing significant progress alongside continued unmet need. These developments provide important context for understanding how integrative approaches can complement – not replace – conventional medical care.
The FDA has approved several disease-modifying treatments targeting amyloid plaques, and additional pipeline therapies are under review. At the same time, NIH-funded research increasingly includes lifestyle intervention trials, signaling growing recognition that pharmaceutical and integrative strategies can work together.
In July 2024, the FDA approved donanemab (Kisunla) for adults with early symptomatic Alzheimer’s disease. In the TRAILBLAZER-ALZ 2 Phase 3 trial, donanemab slowed cognitive and functional decline by up to 35% in patients with less advanced pathology at 18 months and reduced the risk of progressing to the next clinical stage by 37%.
Additional FDA decisions are pending in 2026, including AXS-05 for Alzheimer’s-related agitation, a Leqembi at-home autoinjector, and results from several Phase 3 trials. These developments represent meaningful progress, though no current drug halts or reverses the disease entirely.
The National Institute on Aging reports that NIH currently funds more than 230 active clinical trials testing new drug candidates and lifestyle interventions to prevent or treat Alzheimer’s and related dementias, as documented in the 2024 NIH Dementia Research Progress Report. Notably, these trials include not only pharmaceutical candidates but also studies on personalized health coaching, multivitamin cognitive benefits, and hearing interventions – reflecting growing government investment in integrative strategies.
A 2025 study in JAMA Network Open examining patient and care partner perspectives found that treatment decisions involve careful weighing of potential benefits against burdens such as infusion schedules, monitoring requirements, and side effects. Many individuals and families seek proactive strategies that address overall brain health rather than relying solely on single-drug approaches. This desire for comprehensive care naturally leads to interest in integrative medicine as a complement to conventional treatment.
Integrative approaches to cognitive health combine evidence-based lifestyle interventions – including nutrition, exercise, stress management, sleep optimization, and social engagement – with conventional medical care to address the multiple factors contributing to dementia risk. Research published in Frontiers in Pharmacology in 2025 indicates that at least 40% of all dementia cases are linked to modifiable risk factors, suggesting substantial preventive potential.
This 40% figure represents an enormous opportunity. Rather than viewing dementia as an inevitable consequence of aging, integrative medicine targets the specific, controllable factors that contribute to cognitive decline in each individual. The approach aligns with what organizations like AHIMA advocate: patient-centered, comprehensive care that complements and enhances conventional treatment.
A 2025 peer-reviewed article in Frontiers in Pharmacology confirmed that at least 40% of dementia cases are associated with modifiable risk factors. A 2024 study published in PMC examining the American Heart Association’s Life’s Essential 8 framework further reinforced that cardiovascular health metrics directly correlate with cognitive function in older adults.
Key modifiable risk factors for dementia include:
Dale Bredesen, MD – neurologist and Chief Scientific Officer at Apollo Health – has articulated why a personalized, multifactorial approach is essential: “Alzheimer’s has been an untreatable disease. And so, if we’re going to try to treat this previously untreatable disease, why would we do it in a blind fashion by just giving a drug that has nothing to do with what’s actually causing it? Our research showed that this is a multifactorial disease, that there are many potential contributors. And for each person, we want to identify the contributors and target those with a precision medicine type of approach.”
This philosophy aligns directly with integrative medicine’s approach to mild cognitive impairment and early-stage dementia, which seeks to identify each patient’s unique combination of contributing factors and address them through a comprehensive, individualized plan.
Nutrition is one of the most well-studied modifiable factors in cognitive health, with strong evidence linking dietary patterns – particularly the Mediterranean diet – to reduced dementia risk. The 2025 Frontiers in Pharmacology review found that nutritional interventions, when combined with conventional therapies such as cholinesterase inhibitors, produced synergistic outcomes superior to either approach alone.
The Mediterranean diet – rich in vegetables, fruits, whole grains, olive oil, fish, and legumes while limiting processed foods and red meat – has consistently demonstrated cognitive protective effects in clinical research. The Frontiers in Pharmacology review highlighted studies showing that the Mediterranean diet combined with cholinesterase inhibitors produced enhanced outcomes compared to medication alone.
The National Institute on Aging’s cognitive health guidance also recommends dietary patterns rich in vegetables, fruits, and whole grains as part of a comprehensive brain health strategy. Spring 2026 presents an ideal time to refresh nutrition habits, with seasonal produce becoming widely available at Arizona farmers markets and grocers.
The 2024 NIH Dementia Research Progress Report highlights ongoing studies into multivitamin supplementation and cognitive benefits in older adults, with some trials showing promising preliminary results. However, no single supplement has been proven to prevent or treat dementia independently.
Individuals considering nutritional supplements for brain health should consult with a qualified healthcare provider to ensure safety, avoid interactions with existing medications, and prioritize evidence-based options over unverified products.
Physical exercise is among the most strongly supported integrative interventions for cognitive health, with evidence from government agencies, peer-reviewed research, and cardiovascular health frameworks all pointing to its protective effects against dementia. The Life’s Essential 8 study published in PMC in 2024 directly linked physical activity metrics to better cognitive function in older adults.
Based on NIA guidance and the Life’s Essential 8 framework, the following types and amounts of exercise support cognitive health:
| Exercise Type | Recommended Frequency | Examples |
|---|---|---|
| Aerobic exercise | 150 minutes per week (moderate intensity) | Brisk walking, swimming, cycling |
| Resistance training | 2 or more days per week | Weight lifting, resistance bands, bodyweight exercises |
| Balance and flexibility | 2-3 days per week | Yoga, tai chi, stretching routines |
In clinical practice, integrative medicine providers frequently observe that patients who combine multiple exercise types experience broader health benefits – including improved sleep, reduced stress, and better cardiovascular markers – all of which independently support brain health.
Research consistently demonstrates that initiating a regular exercise program at any age produces measurable cognitive benefits. The NIA emphasizes that physical activity remains beneficial even when started later in life, and the Life’s Essential 8 framework measures current health behaviors rather than lifelong patterns.
Spring in Arizona offers ideal conditions to begin an outdoor exercise routine. Moderate morning temperatures support walking, hiking, and group fitness activities – all of which also provide the social engagement that further supports cognitive health.
Mind-body practices including yoga and mindfulness-based stress reduction have demonstrated measurable cognitive benefits when used as complementary therapies alongside conventional dementia treatments. The 2025 Frontiers in Pharmacology review identified specific synergistic outcomes when yoga and meditation were combined with standard pharmaceutical interventions for Alzheimer’s disease.
The Frontiers in Pharmacology review documented studies in which yoga combined with donepezil (a commonly prescribed cholinesterase inhibitor) produced greater cognitive and functional improvements than donepezil alone. These findings position yoga as a genuine complementary therapy rather than an alternative – enhancing rather than replacing conventional treatment.
Yoga’s benefits for cognitive health likely operate through multiple mechanisms, including stress hormone reduction, improved cerebral blood flow, enhanced sleep quality, and increased social engagement through group classes.
Mindfulness-based stress reduction (MBSR) programs have been reviewed in the Frontiers in Pharmacology article as adjuncts to conventional Alzheimer’s therapy, with evidence supporting their role in reducing chronic stress – a factor Dr. Bredesen identifies as a direct contributor to cognitive decline.
Practical ways to incorporate mindfulness into daily routines include:
Sleep quality and social engagement are two independent, modifiable risk factors for dementia that are frequently underaddressed in conventional care. The Life’s Essential 8 framework includes sleep as a core cardiovascular and cognitive health metric, while the National Institute on Aging identifies social engagement as a protective factor against cognitive decline in older adults.
During sleep, the brain’s glymphatic system clears metabolic waste products including amyloid-beta protein – a hallmark of Alzheimer’s disease pathology. Chronic sleep disruption impairs this clearance process and contributes to inflammation, both of which accelerate cognitive decline. The Life’s Essential 8 study reinforced that sleep duration and quality are directly associated with cognitive function in older adults.
Evidence-based sleep hygiene recommendations include maintaining a consistent sleep schedule of 7-9 hours, limiting screen exposure before bed, keeping the bedroom cool and dark, and avoiding caffeine and alcohol in the evening hours.
Social isolation is recognized by the NIA as an independent risk factor for cognitive decline. Regular social interaction provides cognitive stimulation, emotional support, and motivation for physical activity – all of which contribute to brain health preservation.
The 2024 NIH progress report also highlights ongoing studies on hearing aid interventions, reflecting growing evidence that untreated hearing loss contributes to social withdrawal and accelerated cognitive decline. Addressing hearing health through screening and treatment removes a significant barrier to the social engagement that protects brain function.
Integrative and conventional treatments for cognitive health are most effective when used together in a coordinated care plan, rather than as competing approaches. The 2025 Frontiers in Pharmacology review specifically examined the synergistic outcomes achieved when traditional, complementary, and integrative medicine (TCIM) approaches were combined with conventional pharmaceutical therapies for Alzheimer’s disease.
In integrative medicine, “complementary” refers to therapies that are used alongside – not instead of – conventional medical treatments. This distinction is critically important in dementia care. For example, yoga practiced alongside prescribed cholinesterase inhibitors is a complementary approach. Abandoning prescribed medication in favor of yoga alone would be an alternative approach and is not supported by current evidence.
The Frontiers in Pharmacology review consistently framed integrative interventions as adjuncts that enhance conventional treatment outcomes, reinforcing the complementary framework.
Transparency with all healthcare providers about every therapy being used – including supplements, dietary changes, mind-body practices, and any complementary treatments – is essential for safe, effective care. Potential interactions between supplements and prescribed medications require professional oversight.
Integrative medicine physicians are specifically trained to coordinate complementary and conventional approaches. When selecting a provider, look for board certifications in integrative medicine, experience with neurodegenerative conditions, and a willingness to collaborate with your existing care team.
Spring 2026 offers a natural opportunity to implement evidence-based cognitive health strategies, with warmer weather supporting outdoor activity, seasonal produce enhancing nutrition, and renewed energy motivating new wellness routines. The following checklist consolidates the integrative approaches supported by the research reviewed in this article:
The NIA’s Cognitive Health and Older Adults resource provides additional government-endorsed guidance on each of these strategies.
No, cognitive decline is not an inevitable part of aging. Research published in Frontiers in Pharmacology in 2025 indicates that at least 40% of dementia cases are linked to modifiable risk factors including diet, exercise, sleep, stress, and social engagement. Dr. Dale Bredesen has described cognitive decline as “often the result of a confluence of factors” that can be identified and addressed rather than accepted as unavoidable.
At least 40% of all dementia cases have been linked to modifiable risk factors, according to a 2025 peer-reviewed article published in Frontiers in Pharmacology. “Modifiable” means these factors can be changed through lifestyle interventions – including improving nutrition, increasing physical activity, optimizing sleep, managing stress, maintaining social connections, and controlling cardiovascular risk factors such as blood pressure and blood sugar.
No single approach – conventional or integrative – currently cures Alzheimer’s disease. Integrative strategies focus on risk reduction, slowing disease progression, and improving quality of life as complements to conventional medical treatment. The strongest evidence supports using integrative approaches for prevention and as adjuncts to FDA-approved therapies, not as standalone cures.
The Arizona Homeopathic and Integrative Medical Association (AHIMA) serves as a resource for individuals seeking qualified integrative medicine practitioners in Arizona. When evaluating providers, look for board certification in integrative or functional medicine, experience with cognitive health and neurodegenerative conditions, a collaborative approach with conventional physicians, and willingness to develop personalized, evidence-based treatment plans.
When properly coordinated under professional guidance, combining integrative and conventional dementia treatments has demonstrated synergistic benefits in published research. However, potential risks exist – particularly with supplements that may interact with prescribed medications. The Frontiers in Pharmacology review emphasized that optimal outcomes require coordination between providers. Always inform all of your healthcare providers about every supplement, dietary change, or complementary therapy you are using.
The evidence is clear that cognitive health is not solely determined by genetics or age. With at least 40% of dementia cases linked to modifiable risk factors, individuals have meaningful opportunities to reduce their risk through integrative, evidence-based strategies – particularly when these are combined with appropriate conventional medical care.
For additional information and resources, the National Institute on Aging’s cognitive health page provides government-endorsed guidance, while the Alzheimer’s Association offers comprehensive statistics and support services. AHIMA continues to support Arizona residents in accessing qualified integrative medicine practitioners who can develop personalized cognitive health plans in coordination with conventional care teams.
Taking action this spring – whether through improved nutrition, increased physical activity, better sleep habits, or a conversation with an integrative medicine provider – represents a meaningful investment in long-term brain health.
At least 40% of all dementia cases are linked to modifiable risk factors, according to a 2025 peer-reviewed study published in Frontiers in Pharmacology. These preventable factors include poor nutrition, physical inactivity, chronic sleep disruption, unmanaged stress, social isolation, untreated hearing loss, and poorly controlled cardiovascular health markers such as blood pressure and blood sugar.
No single approach – conventional or integrative – currently cures or reverses Alzheimer’s disease. Integrative strategies such as nutrition optimization, exercise, stress reduction, and sleep improvement focus on reducing dementia risk, slowing disease progression, and enhancing quality of life. Research supports using these interventions alongside FDA-approved treatments rather than as standalone replacements for conventional medical care.
Research based on National Institute on Aging guidance and the Life’s Essential 8 framework recommends at least 150 minutes of moderate aerobic exercise per week, such as brisk walking or swimming, plus resistance training two or more days per week. Adding balance and flexibility activities like yoga or tai chi two to three days weekly provides additional cognitive and physical benefits.
No, starting brain-healthy habits at any age produces measurable cognitive benefits. The National Institute on Aging emphasizes that physical activity, improved nutrition, better sleep, and increased social engagement remain beneficial even when initiated later in life. The Life’s Essential 8 cardiovascular health framework measures current health behaviors rather than lifelong patterns, reinforcing that positive changes matter at every stage.
The Mediterranean diet – rich in vegetables, fruits, whole grains, olive oil, fish, and legumes while limiting processed foods – has consistently shown cognitive protective effects in clinical studies. A 2025 Frontiers in Pharmacology review found that combining the Mediterranean diet with conventional Alzheimer’s medications such as cholinesterase inhibitors produced enhanced outcomes compared to medication alone, supporting its role as a complementary strategy.
During sleep, the brain’s glymphatic system clears metabolic waste products including amyloid-beta protein, a hallmark of Alzheimer’s disease. Chronic sleep disruption impairs this clearance process and increases inflammation, both of which accelerate cognitive decline. Experts recommend maintaining a consistent schedule of seven to nine hours of quality sleep nightly as a core component of brain health preservation.
Research published in Frontiers in Pharmacology in 2025 found that yoga combined with donepezil, a commonly prescribed Alzheimer’s medication, produced greater cognitive and functional improvements than donepezil alone. Yoga and mindfulness-based stress reduction likely benefit the brain through multiple mechanisms including stress hormone reduction, improved blood flow, better sleep quality, and enhanced social engagement through group practice.